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Abstract
Objective—As a major cellular defense mechanism, the Nrf2/Keap1 pathway regulates
expression of genes involved in detoxification and stress response. Our previous study revealed
activation of the Nrf2/Keap1 pathway at the maturation phase during mouse esophageal
development, suggesting a potential function in epithelial defense. Here we hypothesize that Nrf2
is involved in the barrier function of esophageal epithelium, and plays a protective role against
gastroesophageal reflux disease (GERD).
Design—Human esophageal biopsy samples, mouse surgical models and Nrf2-/- mice were used
to assess the role of the Nrf2/Keap1 pathway in esophageal mucosal barrier function. Trans-
epithelial electrical resistance (TEER) was measured with mini-Ussing chambers. Hematoxylin
and eosin (HE) staining and transmission electron microscopy were used to examine cell
morphology, while gene microarray, immunohistochemistry, Western blotting and ChIP analysis
were used to assess the expression of pathway genes.
Results—Nrf2 was expressed in normal esophageal epithelium and activated in GERD of both
humans and mice. Nrf2 deficiency and gastroesophageal reflux in mice, either alone or in
combination, reduced TEER and increased intercellular space diameter in esophageal epithelium.
Nrf2 target genes and gene sets associated with oxidoreductase activity, mitochondrial biogenesis
and energy production were down-regulated in the esophageal epithelium of Nrf2-/- mice.
Consistent with the antioxidative function of Nrf2, a DNA oxidative damage marker (8OHdG)
dramatically increased in esophageal epithelial cells of Nrf2-/- mice compared with those of wild-
type mice. Interestingly, ATP biogenesis, Cox IV (a mitochondrial protein) and Claudin-4 (Cldn4)
expression were down-regulated in the esophageal epithelium of Nrf2-/- mice, suggesting that
energy-dependent tight junction integrity was subject to Nrf2 regulation. ChIP analysis confirmed
the binding of Nrf2 to Cldn4 promoter.
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Conclusion—Nrf2 deficiency impairs esophageal barrier function through disrupting energy-
dependent tight junction. Elucidating the role of this pathway in GERD has potential implications
for the pathogenesis and therapy of the disease.
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INTRODUCTION
The barrier function of the stratified squamous epithelium of the esophagus is very
important to protect the organism from the environment. The intrinsic resistance of
esophageal epithelium is composed of three compartments:1 (1) Pre-epithelial defense
including the mucus layer (minimal to non-existent), unstirred water layer, and surface
bicarbonate ion concentration; (2) Epithelial defense including cell membranes, intercellular
junctional complex (tight junctions, glycoprotein matrix and buffers), intracellular buffers,
and membrane ion transporters; (3) Post-epithelial defense including blood flow and acid-
base balance. Any defects of one or more of these defense mechanisms contribute to
gastroesophageal reflux disease (GERD), which is manifested as damage to the esophageal
epithelium from exposure to the gastrointestinal refluxate.2 Therefore, studies on the
molecular aspects of these defense mechanisms may help us develop strategies to improve
the esophageal barrier against gastroesophageal reflux.
As a major cellular defense pathway, the Nrf2 (Nfe2l2, nuclear factor erythroid-derived 2-
like 2) pathway is known to regulate expression of enzymes involved in detoxification and
anti-oxidative stress response.3 Nrf2 forms heterodimers with small Maf proteins and binds
to the antioxidant response elements (ARE) of target genes when cells are exposed to
oxidative stress or xenobiotics. Keap1 (Kelch-like ECH-associated protein 1) regulates the
function of Nrf2 by retaining Nrf2 in the cytoplasm under normal physiological conditions,
and by allowing nuclear translocation of Nrf2 under stress conditions.4 Interestingly,
constitutive activation of Nrf2 in Keap1-/- mice led to hyperkeratosis in the esophagus and
forestomach.5 Our gene expression array data revealed that Nrf2/Keap1 pathway was
activated at the maturation phase during mouse esophageal epithelial development.6 At this
phase, the keratinized stratified squamous epithelium continues to thicken and finally forms
the esophageal epithelium in adults. Since the keratinized layer is the major protective layer
against physical stress and chemical injuries,7 and terminally differentiated keratinocytes
express proteins which can provide protection by quenching reactive oxygen species,8 we
hypothesized that Nrf2 may be involved in esophageal epithelial barrier function, and may
therefore play a protective role during gastroesophageal reflux.
In this study, we observed Nrf2 expression in normal esophageal epithelium and its
activation in GERD of both humans and mice. Nrf2-/- mice were then compared with wild-
type mice for esophageal barrier function, morphology, and gene expression in the presence
of gastric, duodenal or mixed reflux. Our study demonstrated that Nrf2 deficiency impaired
esophageal barrier function through disrupting energy-dependent tight junction.
METHODS
Human tissue samples
Ten pairs of biopsy tissue samples of normal esophagus and non-erosive GERD diagnosed
by a gastroenterologist were obtained during routine upper endoscopy from the outpatient
endoscopy suites of the University of North Carolina Hospitals. Patients with non-erosive
reflux disease all had at least one previous endoscopy while off all antisecretory therapy for
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at least 4 weeks which demonstrated no mucosal breaks. At the time of the study endoscopy,
all GERD patients were on proton pump inhibitors for at least 2 month duration, but
continuing to experience some symptoms of GERD (heartburn and/or regurgitation). All
patients and controls were Caucasian males. The mean age of GERD patients was 63 yrs
(SD 3.6) and of controls 57 yrs (SD 4.4). Biopsy tissue samples were harvested during from
the 5 cm proximal to the GE junction on endoscopic examination. Use of human samples
was approved by the Institutional Review Board. All human samples were coded with
patient identifiers removed.
Animals and surgical models
Wild-type C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME).
Nrf2-/- mice on C57BL background were obtained from the Experimental Animal Division,
RIKEN Biosource Center (Tsukuba, Japan). All animal experiments were approved by the
Institutional Animal Care and Use Committees at North Carolina Central University
(protocol number XC-12-03-2008).
Eight-week-old wild-type and Nrf2-/- mice were housed five per cage respectively, given a
diet and water ad libitum and maintained on a 12h light-dark cycle. These mice were
administered anesthetics pre-mixed in normal saline (80mg/kg ketamine and 12mg/kg
xylazine, i.p.). All surgeries were performed through an upper midline incision. (1)
Esophagogastric anastomosis (Figure 2A): Three incisions of ~5 mm were made on the
distal esophagus and the forestomach, and then sutured longitudinally with accurate mucosal
to mucosal opposition, for example, point a with b, point c with d. (2)
Esophagogastroduodenal anastomosis (Figure 2B): Two 5-mm incisions were made on the
esophagus and the duodenum, and then anastomosed together with accurate mucosal to
mucosal opposition. (3) Esophagogastroduodenal anastomosis plus gastrectomy (Figure 2C):
In addition to esophagogastroduodenal anastomosis, the stomach was removed after ligating
at the gastroesophageal junction and the pylorus. After anastomoses, the abdominal cavity
was washed and closed with 6-0 silk suture. Esophagogastric anastomosis was designed to
eliminate the sphincter function and allow free gastric reflux, whereas
esophagogastroduodenal anastomosis plus gastrectomy and esophagogastroduodenal
anastomosis were for duodenal reflux and mixed reflux, respectively.
Transepithelial electrical resistance (TEER)
Esophageal epithelial tissues for chamber studies were immersed in ice-cold oxygenated
Ringer’s solution and immediately transported to the laboratory for mounting mucosal side
up in mini-Ussing chambers as previously described 9. After equilibration for 30 min, basal
electrical readings of PD, Isc, and RT were obtained every 15 min for two hours. Total
electrical resistance (RT) was calculated using Ohm’s law, where PD = Isc× RT.
Transmission electron microscopy (TEM)
Three mice of each group were sacrificed and the esophageal epithelial tissues were
dissected. The tissue was fixed with 4% glutaraldehyde in cacodylate buffer for at least one
hour and then washed in buffer and postfixed for 1 hr in 1% OsO4 in the same buffer. It was
washed in veronal acetate buffer, stained for 1 hr in 0.5 uranyl acetate in the same buffer,
dehydrated using a graded ethanol series, and embedded in Poly/Bed 812 resin
(Polysciences Warrington, PA). Thick and thin sections were prepared on a Reichert-Jung
ultramicrotome (Leica, Bannockburn, IL). Thick sections (0.5 micrometer) on slides were
stained with 1% toluidine blue-borax for light microscopy selection of the appropriate areas
for thin sections; thin sections were mounted on copper grids and double stained with 2%
uranyl acetate and Reynolds’ lead citrate. The grids were examined using a Philips CM 12
electron microscope (FEI, Hillsboro, OR). From each sample, intercellular space (ICS) and
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density of electron-dense material between >30 randomly selected basal cells were measured
on three photomicrographs with the MicroSuite Biological Suite (Olympus, Center Valley,
PA). At least ten randomly selected cells were used for the measurement. The ICS was
measured as the area between cell membrane of two adjacent cells. Density of electron-
dense material in ICS was calculated as the average gray value divided by ICS. ANOVA test
was performed to compare the differences between groups.
RNA isolation and microarray analysis
Three mice of each group were sacrificed and the esophageal epitheliums were dissected.
Total RNA was extracted from individual mouse esophagi with an RNeasy Fibrous Tissue
Mini Kit (Qiagen, Valencia, CA). These RNA samples were checked for their quality using
gel electrophoresis and their concentrations were measured using spectrophotometry. RNA
quality (RIN>7) was further checked with Bioanalyzer (Agilent Technologies, Santa Clara,
CA).
Microarray experiments with mouse samples were performed with Agilent two-channel
mouse 4×44k microarrays in the Genomics Core of University of North Carolina at Chapel
Hill. Data preprocessing was carried out via UNC Microarray Database for quality filtering
and data normalization. The retrieved matrix data was collapsed onto Gene symbol as the
gene expression value. Differentially expressed genes (DEGs) were obtained from two-class
SAM in Excel with the median number of false positives less than 1. GSA was carried out as
an add-in in Excel. Curated gene sets in two major categories - canonical pathway (CP; 880
gene sets) and Gene Ontology (GO; C5, 1,454 gene sets) - were downloaded from the GSEA
web portal and used in this study (http://www.broadinstitute.org/gsea/index.jsp). 1000
permutations were applied to generate a null distribution for statistical testing, and
significantly enriched gene sets were obtained at a false discovery rate (FDR) cutoff of 0.5.
The microarray data were submitted to the GEO database (GSE39629).
Western blotting
Two 3-month-old mice of were sacrificed and the esophageal epitheliums were dissected.
Total proteins were isolated from the individual esophageal epithelium , tongue tissue and
liver tissue by an adaptation of a previously described method.9 Protein concentration was
determined by the BCA protein assay (Pierce; Rockford, IL). Protein samples were
separated by PAGE, and transferred to a PVDF membrane. After blocking with 0.5% non-
fat dry milk, the membrane was probed with a rabbit anti-Claudin-1 polyconal antibody
diluted at 1: 50 (LS-B6327, Cell Signaling Technology, Danvers, MA), a rabbit anti-
Claudin-4 polyclonal antibody diluted at 1: 25 (LS-B2370, Cell Signaling Technology) or 3
μg/ml mouse anti-Cox IV monoclonal antibody (ab14744, Abcam; Cambridge, MA) at 4°C
overnight. We use 0.4 μg/ml rabbit anti-Nrf2 polyclonal antibody (H-300, Santa Cruz
Biotechnology, Santa Cruz, CA) for confirmation of the absence of Nrf2 protein in the
esophageal epithelium of Nrf2-/- mice (Figure S2). The membrane was then incubated with
HRP-conjugated anti-mouse or anti-rabbit secondary antibody. Immunoreactivity was
visualized by applying HRP ECL substrate (Pierce) and immediately exposing the
membranes to X-ray film. To verify equal loading of samples, the blots were stripped and
re-probed with mouse anti-β-actin monoclonal antibody diluted at 1:2500 (A-5441, Sigma-
Aldrich; St. Louis, MO).
Histochemical and immunohistochemical staining
Tissues were routinely processed for paraffin sectioning (5μm). HE staining was carried out
with standard protocols. The thickness of the keratinized layer was measured on HE stained
sections using MicroSuite Biological Suite. For immunohistochemical staining, the
deparaffinized sections were submerged in methanol containing 0.3% hydrogen peroxide for
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15 min at RT to inhibit endogenous peroxidase activity. Antigen retrieval was done prior to
incubation with 1:100 diluted rabbit anti-Nrf2 polyclonal antibody (PA1-38312, Thermo
Scientific, Rockford, IL), 1:50 diluted rabbit anti-HO1 polyclonal antibody (ab52947,
Abcam), 5 μg/ml rabbit anti-Claudin 1 polyclonal antibody (51-9000, Invitrogen), 10 μg/ml
mouse anti-Claudin 4 monoclonal antibody (32-9400, Invitrogen), or 1.25 μg/ml mouse
anti-8OHdG monoclonal antibody (ab48508; Abcam) overnight at 4°C. We use anti-Keratin
5 antibody () as standard control for IHC (Figure S3), Tissue sections were then washed
again in PBS and incubated with peroxidase-conjugated secondary antibodies for 30 minutes
at 37°C. Detection of the antibody complex was done using the streptavidin-peroxidase
reaction kit with DAB as a chromogen (ABC kit, Vector Labs; Burlingame, CA).
The percentage of Nrf2 positive cells/total cells and cells with nuclear staining/total positive
cells on the 10 human samples of normal and GERD, and 3 mouse samples of NOC, gastric,
duodenal and mixed reflux model were calculated and statistically analyzed. The percentage
of positively stained cells was measured in three wild-type and three Nrf2-/- mice. Three
sections were used for each sample. Statistical analysis was performed to compare the
expression level of 8OHdG in wild-type and Nrf2-/- mice.
Measurement of ATP concentration
Esophageal epithelial tissue samples were weighed and homogenized in 400 μl 5% TCA.
The supernatant was diluted 1:10 with distilled water for ATP measurement using a
bioluminescence ATP assay kit according to the manufacturer’s instructions (EnzyLight
ATP assay kit; BioAssay Systems; Hayward, CA). The luminescence signal was measured
within 3 min using the ATP luminometry mode in a plate reader (Wallac Victor3;
PerkinElmer; Hanover, MD) with an integration time of 1.0 s and calibrated to a standard
curve. The concentration of ATP was calculated by dividing the total amount by the weight
of each sample.
Chromatin immunoprecipitation (ChIP)
Nrf2 binding sites within the 5kb 5′-upstream DNA sequence of Cldn4
(ENSMUSG00000047501) were predicted using Anchored Combination TFBS Cluster
Analysis (oPOSSUM version 3.0).10 The “Conserved Binding Site Cluster Combinations”
(TGAGTCA) were found at −341bp ~ −347bp and −423bp ~ −429bp upstream of Cldn4.
ChIP analysis was performed in triplicate using an EZ-ChIP kit (Millipore; Billerica, MA)
according to the manufacturer’s instructions. Immunoprecipitations were performed using
control mouse IgG or 2 μg/ml rabbit anti-Nrf2 polyclonal antibody (H-300, Santa Cruz
Biotechnology). Two μl of the immunoprecipitated DNA or input was used for 35 cycles of
PCR with the following primer pairs: Cldn4 (5′-GTTGTCCCCACCCGGTGAGCATC-3′
and 5′-GGCCAACAAAGGCGTTCAGAGGC-3′; predicted size: 168 bp); Nqo1 (5′-
GCAGTTTCTAAGAGCAGAACG-3′ and 5′-GTAGATTAGTCCTCACTCAGCCG-3′;
predicted size: 176 bp); P63 (5′-CAAATGTTGCTTGTCTGGTG-3′ and 5′-
GTCAGTCGAGTGCACAGTTT-3′; predicted size: 210 bp). As a known Nrf2 target gene,
Nqo1 serves as a positive control, and P63 as a negative control.
RESULTS
Activation of Nrf2 in esophageal epithelial cells by gastroesophageal reflux
Nrf2 expression was examined in ten human biopsy samples of normal esophagus and
GERD. In normal esophagus (Figure 1A), Nrf2 protein was detected mostly in the
cytoplasm of superficial cells (Figure 1C), but not in basal cells (Figure 1E). However, in
GERD biopsies (Figure1 B), immunostaining showed overexpression and nuclear
localization of Nrf2 in superficial cells (Figure 1D) and basal cells (Figure 1F).The number
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of cells was counted, the percentages were calculated and the statistical significances were
analyzed. The positive stained cells were 18.2±1.8% of the total cells in normal esophageal
epithelium and 39.7±7.6% in GERD. Statistical analysis showed the up-regulation of Nrf2
protein in GERD was significant (P<0.05) (Figure 1I). The cells with nuclear staining were
8.7±1.9% of the total positive cells in normal esophageal epithelium and 93.3±11.6% in
GERD. Statistical analysis showed the amount of Nrf2 protein in nuclear is significantly
higher in GERD (P<0.001) (Figure 1J). The expression of HO1, a canonical Nrf2 target
gene, was also examined by immunohistochemistry, The result showed HO1 was up-
regulated in GERD (Figure 1G, H). These data suggested that, as an integral part of the
molecular network in normal esophageal epithelial cells, Nrf2 was activated by
gastroesophageal reflux.
To further investigate the involvement of Nrf2 in GERD, three surgical mouse models were
developed to produce gastric reflux (Figure 2A), duodenal reflux (Figure 2B), or mixed
reflux (Figure 2C)Three mice of each group were used for further experiments. In normal
mouse esophageal epithelium, Nrf2 protein was localized in the cytoplasm of superficial and
parabasal cells. Nuclear localization was observed in superficial, parabasal and basal cells 4
weeks after gastric reflux (Figure 2E), duodenal reflux (Figure 2F), or mixed reflux (Figure
2G). The positively stained cells were 23.9±4.1% of the total epithelial cells in control mice,
54.2±5.1% in gastric reflux (P<0.001), 72.1±4.3% in duodenal reflux (P<0.001), and
35.6±5.8% in mixed reflux (P<0.001; as compared to the control) (Figure 2H). Positive cells
with nuclear staining were 27.9±2.1% of the positively stained cells in control mice,
66.3±7.3% in gastric reflux (P<0.001), 89.7±2.9% in duodenal reflux (P<0.001), and
63.3±1.3% in mixed reflux (P<0.001; as compared to the control) (Figure 2I). The
expression of HO1, a canonical Nrf2 target gene, was also examined by
immunohistochemistry (Figure 2J, K, L, M). The result showed HO1 was up-regulated in
mouse model of duodenal reflux and mixed reflux (Figure 2L, M). These results confirmed
Nrf2 activation during gastroesophageal reflux in mice, and prompted us to further study the
role of Nrf2 in the esophagus using these models.
Impaired barrier function of the esophageal epithelium in Nrf2-/- mice
As an indicator of barrier function, TEER of esophageal epithelium in Nrf2-/- mice was
significantly lower than that in wild-type mice at each time point (Figure 3A), suggesting a
protective role of Nrf2 against ion transport in esophageal epithelium. We further measured
TEER of esophageal epithelium in wild-type and Nrf2-/- mice 4 weeks after reflux surgery.
Significant decrease in esophageal TEER was observed in both wild-type and Nrf2-/- mice
after gastroesophageal reflux, especially in those with gastric or duodenal reflux (Figure
3B). - Nrf2 deficiency further reduced esophageal TEER after gastric or mixed reflux
(P<0.01), but not after duodenal reflux. Dramatic decrease of TEER after duodenal reflux
overshadowed the effect of Nrf2 deficiency. These data demonstrated a protective role of
Nrf2 in epithelial resistance both in the presence and absence of gastroesophageal reflux.
Histological and ultrastructural changes in the esophageal epithelium of Nrf2-/- mice
In order to understand the structural basis of Nrf2 function in esophageal epithelium,
esophageal tissue sections of wild-type and Nrf2-/- mice were compared. On HE-stained
sections, no obvious histological changes could be observed in the esophageal epithelium of
Nrf2-/- mice as compared with wild-type mice (Figure S1A, B). Since a previous study
suggested Nrf2 deficiency impacted the cornification of esophageal epithelium,11 we
measured the thickness of esophageal epithelium in wild-type and Nrf2-/- mice. However,
we did not observe any difference between wild-type and Nrf2-/- mice (Figure S1C).
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Under TEM, dilated intercellular spaces (DIS) and a decrease of the number of mitochondria
were observed in the basal layer of the esophagus from Nrf2-/- mice (Figure 4E), as
compared to wild-type (Figure 4A). In Nrf2-/- samples, there were fewer visible
desmosomes and less electron-dense materials between basal cells (Figure 4E), suggesting
weakened cell-cell adhesion between basal cells in Nrf2-/- mice. There were also fewer
cellular processes extending from basal cells into basal lamina in Nrf2-/- mice (Figure 4E),
suggesting weakened cell-matrix adhesion in Nrf2-/- mice.
After exposure to reflux for 4 weeks, DIS was observed in the basal layer of esophageal
epithelium of wild-type mice (Figure 4B, C, D). Nrf2 deficiency aggravated these
ultrastructural changes in esophageal epithelial of Nrf2-/- mice (Figure 4F, G, H). This was
especially obvious in the case of gastric reflux (Figure 4B and 4F). Quantitative analysis
confirmed a significant increase of intercellular space between basal cells of Nrf2-/- mice as
compared to wild-type (Figure S4A), and a significant decrease of electron-dense materials
(Figure S4B). This tendency was especially significant in the presence of gastric reflux.
Differentially expressed genes and gene sets in esophageal epithelium of wild-type and
Nrf2-/- mice
To further understand the molecular mechanism of impaired esophageal barrier function in
Nrf2-/- mice, gene expression microarray was performed on wild-type and Nrf2-/-
esophageal epithelial samples (three of each group). SAM analysis revealed that 15 known
Nrf2 target genes (Akr1b8, Gclc, Gsta3, Gstm1, Gstm3, Nfe2l2, Nqo1, Ahsg, Ces1, Esd,
Gstp1, Mgst1, Npn3, Pparg and Selenbp2) were down-regulated in Nrf2-/- mice as compared
with wild-type mice (Suppl. Excel 1). Since these genes are known to be associated with
stress response and detoxification, our data suggest that Nrf2 is normally activated in the
esophageal epithelium of wild-type mice in order to provide protection against physiological
stress.
In the presence of gastric reflux, 7 known Nrf2 target genes (Nqo1, Gstm1, Akr1b8, Gstm3,
Gclc, Pln, Gstp1) were down-regulated in Nrf2-/- mice as compared to wild-type. In the
presence of duodenal reflux, 5 known Nrf2 target genes (Nfe2l2, Nqo1, Gstm1, Gstm3,
Ptgr1) were down-regulated. In the presence of mixed reflux, 24 known Nrf2 target genes
(Gstm1, Gsta3, Gstm3, Nfe2l2, Nqo1, Gstm2, Blvrb, Hmox1, Entpd5, Cbr3, Ppp1r12b,
Gclc, Mgst3, Gstm5, Txnrd1, Cat, Meis1, Ftl1, Sdpr, Selenbp2, Pparg, Gstp1, Esd, Mgst1)
were down-regulated (Suppl. Excel 1).
We also analyzed array data to identify differentially expressed gene sets with GSA. Twenty
gene sets related to response to stimulus/stress and oxidoreductase activity were down-
regulated in the esophageal epithelium of Nrf2-/- mice as compared with wild-type mice.
Consistent with the observation of fewer mitochondria in the basal cells of Nrf2-/- mice, 11
gene sets associated with mitochondrial biogenesis and 32 gene sets associated with
metabolism and energy were down-regulated in the esophageal epithelium of Nrf2-/- mice
(Suppl. Excel 2).
Increased oxidative damage and mitochondrial dysfunction in the esophageal epithelium
of Nrf2-/- mice
Since Nrf2 deficiency resulted in down-regulation of response to stimulus/stress and
oxidoreductase activity, we examined the level of 8OHdG, an oxidative DNA damage
marker, in the esophageal epithelium with immunostaining. It was clear that 8OHdG
dramatically increased in the nuclei of the esophageal epithelial cells in Nrf2-/- mice as
compared to wild-type (Figure 5A, B, A’, B’). The percentage of 8OHdG positive cells
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significantly increased in Nrf2-/- mice (47.5±3.0%) as compared with wild-type mice
(9.4±1.8%) (P<0.001) (Figure 5E).
We also measured ATP concentration and expression of a mitochondrial marker protein
(Cox IV) in the esophageal epithelium. ATP concentration decreased significantly in the
esophageal epithelium of Nrf2-/- mice as compared to wild-type (Figure 5D). Meanwhile,
down-regulation of Cox IV was detected with Western blotting (Figure 5C), and
quantification analysis showed significant decrease of Cox IV protein in Nrf2-/- mice (Figure
5 F). These results suggested mitochondrial dysfunction in the esophageal epithelium of
Nrf2-/- mice.
Down-regulation of Cldn4 in the esophageal epithelium of Nrf2-/- mice
The tight junction is the most important barrier in epithelial tissues, and a key protein
constituent of the tight junction is transmembrane claudins (Cldn).12 Of 24 family members,
Claudin 4 (Cldn4) and Claudin 1 (Cldn1) are the dominant ones in normal esophageal
epithelium.9 Therefore, we examined the expression of Cldn4 and Cldn1 in the esophageal
epithelium of mice.
Immunostaining showed Cldn4 expression in the cytoplasm and cell membrane of
esophageal epithelial cells of wild-type mice (Figure 6A), and its down-regulation in Nrf2-/-
mice (Figure 6C). Western blotting confirmed down-regulation of Cldn4 by 33% in the
esophageal epithelium of Nrf2-/- mice as compared with wild-type mice (Figure 6E). No
obvious change of Cldn1 expression was observed in Nrf2-/- mice (Figure 6B, D).
Nrf2 binding sites within the 5kb 5′-upstream DNA sequence of Cldn4
(ENSMUSG00000047501) were predicted using Anchored Combination TFBS Cluster
Analysis (oPOSSUM version 3.0). 10 The “Conserved Binding Site Cluster Combinations”
(TGAGTCA) were found at −341bp ~ −347bp and −423bp ~ −429bp upstream of Cldn4.
Using Anchored Combination TFBS Cluster Analysis (oPOSSUM version 3.0) we also
analyzed 5,000-bp upstream DNA sequence of murine Cldn1 for potential Nrf2 binding
sites. Absence of such sites explains why Nrf2-/- mice expressed the same amount of Cldn1
as wild-type mice.
ChIP analysis confirmed the direct binding of Nrf2 on the predicted AREs of Cldn4 (Figure
6F) in the esophageal epithelium of both non-operated mice and the duodenal reflux model.
Nrf2 binding to Nqo1 was also detected by ChIP as a positive control of Nrf2 target gene.
Contamination of genomic DNA was controlled by amplification of a 210 bp segment of
P63 gene which is not bound by Nrf2.
DISCUSSION
This study is the first to demonstrate a critical role of Nrf2 in esophageal barrier function.
With three surgical models of GERD in mice, we demonstrated that gastroesophageal reflux
activated Nrf2 as a defense mechanism. Our data suggested that Nrf2 deficiency impaired
the energy-dependent tight junctions in the esophageal epithelium through mitochondrial
dysfunction and Cldn4 down-regulation.
Gastroesophageal reflux is known to produce oxidative stress in the esophageal
epithelium.13 Oxidative damage has long been proposed as one of the mechanisms for
GERD, Barrett’s esophagus and adenocarcinoma. 14 As a major cellular defense mechanism
against oxidative stress, the Nrf2/Keap1 pathway regulates expression of enzymes involved
in detoxification and anti-oxidative stress response.3 Using human samples and mouse
surgical models, we found Nrf2 was activated in GERD as evidenced by its nuclear
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localization and overexpression (Figure 2). Consistent with our observations, previous
studies on rat models of GERD also showed up-regulation of Nrf2 target genes, such as
HO1, MT1. 1516
Since oxidative stress is known to impair the epithelial barrier function in the gut, the
stomach and the trachea, 171819 we studied the role of Nrf2 in esophageal barrier function
using wild-type and knockout mice. Nrf2 deficiency clearly reduced TEER without reflux
(Figure 3A), suggesting a baseline protection by Nrf2 under physiological conditions. In
mice models of GERD, Nrf2 also showed a protective function, especially in the presence of
gastric or mixed reflux. Nrf2 deficiency further reduced TEER that had been suppressed by
reflux (Figure 3B). This is consistent with previous work suggesting that gastroesophageal
reflux produced reactive oxygen species, induced DIS, and impaired the barrier function of
esophageal epithelium. 20, 21, 22
In order to understand how Nrf2 may regulate the barrier function of esophageal epithelium,
we investigated the impact of Nrf2 deficiency on epithelial structure. Microscopically, no
obvious change of cornification was observed on the esophageal epithelium of Nrf2-/- mice
(Figure S1). Under TEM, we noticed DIS and a reduction of mitochondria in the esophageal
epithelium of Nrf2-/- mice as compared with wild-type (Figure 4). Consistent with this
observation, mitochondrion-related gene sets were down-regulated in the esophageal
epithelium of Nrf2-/- mice (Excel S2), and oxidative DNA damage increased in the epithelial
cells of Nrf2-/- mice (Figure 5A, B). Reduction of mitochondria was confirmed by down-
regulation of a mitochondrial marker protein, Cox IV (Figure 5D). Our data were in
agreement with previous studies showing that Nrf2 regulates mitochondrial biogenesis,23
and oxidative stress impairs mitochondrial biogenesis. 24 In fact, mitochondrial dysfunction
and ATP depletion are known to impact the formation and function of tight
junctions. 17, 252627 However, it is still unclear how Nrf2 deficiency may cause
mitochondrial dysfunction, although Keap1 and Nrf2 have been shown to be tethered to
mitochondria through PGAM5 and p62. 2829
The tight junction is known to be the most important structure for epithelial barrier
function,30 and claudins are key tight junction proteins that regulate solute movement across
polarized epithelia.12 We compared expression of Cldn1 and Cldn4 between the esophageal
epithelium of wild-type and Nrf2-/- mice, because these two are the major claudins in normal
esophageal epithelium.9 Both immunostaining and Western blotting showed significant
down-regulation of Cldn4, but not Cldn1, in the esophageal epithelium of Nrf2-/- mice. ChIP
analysis clearly showed binding of Nrf2 to the predicted AREs in the promoter region of
mouse Cldn4 gene (Figure 6). These data are consistent with previous studies in the
literature. In vitro experiments have shown that acid, bile salts, and acidic bile salts
modulated the barrier function of epithelial cells by altering the expression and localization
of Cldn4. 313233 ChIP-seq experiments have showed that Nrf2 binds the ARE motif of
Cldn3 in human lymphoblastoid cells and Cldn4 in mouse embryonic fibroblasts. 3435
Sulforaphane, an Nrf2 activator, significantly increased Cldn5 expression and thus protected
the blood-brain barrier after brain injury. 36 Quercetin, another Nrf2 activator,37 enhanced
intestinal barrier function through up-regulation of Cldn4 in Caco-2 cells.38, 3940 In
summary, our data suggested that Nrf2 deficiency caused mitochondrial dysfunction, down-
regulated Cldn4, and ultimately impaired energy-dependent tight junction in the esophageal
epithelium.
This study focused on comparison between Nrf2-/- and wild-type mice. We did not further
look into mitochondrial dysfunction, oxidative damage and Cldn expression in all three
reflux models. These studies need to be done in the future in order to understand how
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gastroesophageal reflux impairs esophageal barrier function. It is also interesting how Nrf2
may interact with reflux in modulating the barrier function.
Nrf2 activators have been used in clinical trials for human diseases associated with oxidative
stress such as cancer and chronic kidney disease. 4142However, whether Nrf2 interacts with
different refluxes is still unclear. Further study will be done to determine the involvement of
Nrf2 in the three mouse models of GERD.
It should be noted that mouse esophagus is lined by a fully keratinized epithelium that is
more sensitive to duodenal refluxate than to gastric refluxate. Gastric reflux in mouse
esophagus does not produce evident inflammation, unlike gastric acid exposure in the rabbit
model and human patients. Because of these differences between mouse and human
esophagus, mouse models have limitations and further studies are needed before mouse data
can be translated into human studies.
Our study has potentially significant clinical implications: Nrf2 activators may strengthen
the barrier function of esophageal epithelium. As many as 10-40% of patients find their
symptoms inadequately controlled by PPI, especially at night. 43 It remains a clinical
challenge to manage PPI failures. 4445 Nrf2 activators might be an additional pharmaceutical
option to augment the existing treatment modalities. Also, recently radiofrequency ablation
has been established as an effective and safe treatment for Barrett’s with dysplasia. 4647
Ablation restores an endoscopically normal neosquamous epithelium, which is usually
histologically similar to normal esophageal squamous epithelium and does not possess the
molecular alterations characteristic of Barrett’s epithelium. 4849 However, oxidative stress
remains high after ablation, as evidenced by higher levels of 8OHdG and SOD activity. 50
Functionally, the barrier function of the neosquamous epithelium is sub-optimal; its
electrical resistance has been demonstrated to be significantly lower than that of normal
esophagus, and equivalent to GERD.51 Therefore, strengthening the neo-squamous
epithelium with an Nrf2 activator may be a potential solution.
Regardless of these potential treatment ramifications, our observations have implications for
understanding the pathogenesis of GERD. It has long been known that some subjects
tolerate high levels of intra-esophageal acid exposure without developing signs or symptoms
of GERD, while others will manifest severe erosive esophagitis or precancerous lesions at
relatively low levels of acid exposure. Clearly, host factors must play an important role in
GERD susceptibility. However, these factors are poorly understood. If the function of the
Nrf2/Keap1 pathway is integral to mucosal integrity, variability in its function may at least
partially explain the heterogeneous manifestations of GERD. Indeed, genetic polymorphism
of GSTP1, a known Nrf2 target gene, is correlated with a higher grade of esophagitis.52
While our work suggests this intriguing possibility, further investigation will be essential to
establish this pathway as an integral predictor of disease or target for therapies.
In conclusion, our study first demonstrates that Nrf2 deficiency impairs esophageal barrier
function through disrupting energy-dependent tight junction. Elucidating the role of this
pathway in GERD has potential implications for the pathogenesis and therapy of the disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. What is already known about this subject?
a. Constitutive activation of Nrf2 in Keap1-/- mice leads to esophageal
hyperkeratosis.
b. No esophageal phenotype has been reported in Nrf2-/- mice.
2. What are the new findings?
a. Nrf2 is expressed in normal human esophageal epithelium and is activated in
GERD.
b. Gastroesophageal reflux activates the Nrf2 pathway in the esophageal
epithelium of the wild-type mouse as a defense mechanism.
c. Nrf2 deficiency reduces TEER and increases intercellular space in the
esophageal epithelium of Nrf2-/-mice.
d. Oxidative damage in the esophageal epithelium is enhanced in Nrf2-/- mice.
e. Mitochondria and ATP biogenesis are reduced in the esophageal epithelium of
Nrf2-/- mice.
f. A major tight junction protein in the esophagus, Cldn4, is down-regulated in the
esophageal epithelium of Nrf2-/- mice. Nrf2 binds to the promoter of Cldn4
gene.
3. How might it impact on clinical practice in the foreseeable future?
Pharmacological activation of Nrf2 may enhance esophageal barrier function in
gastroesophageal reflux disease.
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Expression of Nrf2 in human biopsy tissue of normal esophagus (A, C, E) and GERD (B, D,
F). Panel C and E are magnifications of panel A, and panel D and F of panel B. (G)
Expression of HO1 in human biopsy tissue of normal esophagus. (H) Expression of HO1 in
human biopsy tissue of GERD. These pictures were representatives of 10 paired samples of
normal esophagus and GERD. (I) Percentage of Nrf2 positive cells of total cells. * P < 0.01
as compared with normal samples. (J) Percentage of the cells with Nrf2 in nucleus of total
positive cells. ** P < 0.001 as compared with normal samples.
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Activation of Nrf2 in esophageal epithelial cells by gastroesophageal reflux in mice. Gastric
reflux (A), duodenal reflux (B) and mixed reflux (C) were induced in mice by
esophagogastric anastomosis, esophagogastroduodenal anastomosis plus gastrectomy,
esophagogastroduodenal anastomosis, respectively. Immunostaining showed over-
expression and nuclear localization of Nrf2 in esophageal epithelial cells 4 weeks after
gastric reflux (E), duodenal reflux (F) and mixed reflux (G) (red arrows). (D) Non-operated
control of Nrf2. (H) Percentage of Nrf2 positive cells of total cells. * P < 0.05 as compared
with wild-type mice. ** P < 0.001 as compared with wild-type mice. (I) Percentage of
nuclear stained cells of total positive cells. ** P < 0.001 as compared with wild-type mice.
Immunostaining for HO1 in esophageal epithelial cells 4 weeks after gastric reflux (K),
duodenal reflux (L) and mixed reflux (M). (J) Non-operated control of HO1. These pictures
were representatives of 3 samples of each group.
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Impaired barrier function of the esophageal epithelium in Nrf2-/- mice. (A) TEER of mouse
esophageal epithelium (means ± SE; n = 6 per group). *P< 0.001 compared to wild-type
controls. (B) Effect of gastric, duodenal or mixed reflux for 4 weeks on TEER of the
esophageal epithelium in wild-type and Nrf2-/- mice (means ± SE; n = 3 per
group). *P<0.001 compared to wild-type/same surgery; a P< 0.01 compared to wild-type/
non-operated control; b P<0.01 compared to Nrf2-/-/non-operated control.
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Morphology and quantification of the ultrastructural changes in the basal cell layer under
TEM (magnification 4,400x; size bar = 2 μm). (A) Wild-type, non-operated control; (B)
Wild-type, gastric reflux; (C) Wild-type, duodenal reflux; (D) Wild-type, mixed reflux; (E)
Nrf2-/-, non-operated control; (F) Nrf2-/-, gastric reflux; (G) Nrf2-/-, duodenal reflux; (H)
Nrf2-/-, mixed reflux. (I) Intercellular space (ICS) between basal cells was measured using
Olympus MicroSuite Biological Suite and statistic analyzed (n=3 per group). ** P<0.01
compared to wild-type/non-operated control; a P <0. 01 compared to wild-type/gastric
reflux; b P< 0.05 compared to wild-type/mixed reflux. (B) Density of electron-dense
material between basal cells was measured using Olympus MicroSuite Biological Suite and
statistic analyzed (n=3 per group). * P<0.05, ** P<0.01, *** P<0.001 compared to wild-
type/non-operated control; ¶ P <0.001 compared to wild-type/gastric reflux.
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Increase of oxidative damage and decrease of mitochondrial function in the esophageal
epithelium of Nrf2-/- mice. (A) Immunostaining of 8OHdG in the esophageal epithelium of
wild-type mice; (B) Immunostaining of 8OHdG in the esophageal epithelium of Nrf2-/-
mice; (A’) and (B’) are magnified pictures showing nuclear staining (red arrows); (C) ATP
concentration in the esophageal epithelium. * P < 0.01 compared to wild-type mice. (D)
Western blotting for a mitochondrial marker protein, Cox IV. (E) Quantification of the IHC
results (A, B). ** P < 0.001. (F) Quantification of the Western blotting results (D), ** P <
0.001.
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Expression of Cldn4 and Cldn1 in the esophageal epithelium of Nrf2-/- mice. (A, C)
Immunostaining for Cldn4; (B, D) Immunostaining for Cldn1. the arrows indicate the cell
membrane . (E) Western blotting for Cldn4 and Cldn1; (F) ChIP analysis of Cldn4. Nqo1
serves as a positive control of Nrf2 target gene, and p63 as negative control for potential
contamination by genomic DNA. (A’), (B’), (C’), (D’) are the magnified pictures showing
the staining on cell membrane.
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